Marinus Pharmaceuticals plans $70M stock sale
December 08, 2020 at 12:14 PM EST
The company's lead new drug candidate is in late-stage testing for a variety of seizure disorders including epilepsy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|